Global Antifungal Drugs Market is estimated to Witness Growth Owing to Rising Incidences of Fungal Infection and Growing Awareness Regarding Fungal Infections

 

Antifungal Drugs Market
Antifungal Drugs Market

Antifungal drugs are used to treat a variety of fungal infections. They are used for both superficial and deep infection. There are three classes of antifungal agents: azoles, polyenes and allylamines. Azoles are fungicidal and inhibit ergosterol synthesis. The azoles are highly effective against a broad spectrum of fungal infections. These compounds are also fungistatic. Some azole-related agents are under development for fungal infections. Azidothymidine is one such drug. It interacts with phospholipids in the fungal cell membrane. This increases permeability, which leads to the loss of intracellular components. Fluconazole is another fungicidal drug. It is used to treat a number of conditions, including AIDS. Several hundred thousand patients in the United States have been treated with fluconazole. Anthelmintic drugs are used to treat helminthiasis, which is a parasitic infection of the intestinal tract. Often, the helminth, such as a roundworm or pinworm, attaches itself to the intestinal wall. Paralysis of the helminth causes it to release its grip on the intestinal wall.

Market Dynamics:  

 

Increasing product launches is estimated to augment growth of the global antifungal drugs market during the forecast period. For instance, Posaconazole a new triazole antifungal drug was launched by Cadila Pharmaceuticals in June 2021. This drug can be used for treating invasive fungal diseases and for Mucormycosis. Moreover, growing drug resistance is anticipated to restrain growth of the global antifungal drugs market during the forecast period.


Impact of COVID-19:

The pandemic was first reported in 2019 in China and it has been transmitted to more than 100 nations. The pandemic affected the healthcare sectors in many nations. Strict lockdowns were imposed in many regions across the world. These lockdowns hampered the growth of many businesses and disrupted many supply chains. These strict measures were imposed in order to prevent the transmission of the virus. Many research organizations and pharmaceutical companies were focusing on developing vaccines and drugs for COVId-19. This affected the growth of the global antifungal drugs market, as COVID-19 patients were prioritized over other diseases. This hampered the growth of the market.

Key Takeaways:

The global antifungal drugs market is estimated to witness robust growth, exhibiting CAGR of XX% during the forecast period, owing to adoption of growing product approvals. For instance, Scynexis gained the approval from United States FDA for Brexafemme in June 2021, used in the treatment of vaginal yeast infections.

North America is anticipated to witness significant growth in the global antifungal drugs market over the forecast period, due to growing prevalence of infectious diseases in the region.

Major players operating in the global antifungal drugs market are Siemens Medical Solutions USA, Inc., Novartis AG, Glenmark, Quest Diagnostics Incorporated, Pfizer, Inc., bioMerieux SA, Bayer AG, Merck & Co., Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Abbott, General Electric Company and Koninklijke Philips N.V.

Comments

Post a Comment

Popular posts from this blog

Recycled Construction Aggregates Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Image
  Recycled Construction Aggregates Market Introduction: The Recycled Construction Aggregates Market has gained significant traction in recent years, driven by increasing environmental concerns, resource scarcity, and the growing emphasis on sustainable construction practices. Recycled construction aggregates, derived from the processing and recycling of construction and demolition waste materials, offer several benefits such as reduced demand for virgin materials, decreased landfill waste, and lower carbon footprint. The market for recycled construction aggregates is expected to witness substantial growth and present lucrative opportunities for market players. Market Size and Share: The global recycled construction aggregates market is projected to surpass  6.2 million tons  by the end of 2027 in terms of volume, exhibiting a CAGR of  6.0%  during the forecast period  (2020 to 2027) . The market is driven by stringent environmental regulations, governmen...
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories ...
Read more

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular t...
Read more